{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:21:48Z","timestamp":1790734908089,"version":"4.1.0"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2013,5,7]],"date-time":"2013-05-07T00:00:00Z","timestamp":1367884800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0064025","type":"journal-article","created":{"date-parts":[[2013,5,8]],"date-time":"2013-05-08T00:53:26Z","timestamp":1367974406000},"page":"e64025","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":150,"title":["Decrease in Irisin in Patients with Chronic Kidney Disease"],"prefix":"10.1371","volume":"8","author":[{"given":"Ming-Shien","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Yung","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuei-Liong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Chun","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,5,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1053\/j.jrn.2010.10.013","article-title":"Energy expenditure in chronic kidney disease patients","volume":"21","author":"CM Avesani","year":"2011","journal-title":"J Ren Nutr"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/sj.ejcn.1602516","article-title":"Resting energy expenditure and its determinants in hemodialysis patients","volume":"61","author":"MA Kamimura","year":"2007","journal-title":"Eur J Clin Nutr"},{"key":"ref3","first-page":"36","article-title":"Weekly energy expenditure and quality of life in hemodialysis patients","volume":"18","author":"I Brenner","year":"2008","journal-title":"CANNT J"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1093\/ndt\/gfh547","article-title":"Decreased resting energy expenditure in non-dialysed chronic kidney disease patients","volume":"19","author":"CM Avesani","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(11)60178-5","article-title":"Chronic kidney disease","volume":"379","author":"AS Levey","year":"2012","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/ajcn\/52.4.596","article-title":"Energy metabolism in acute and chronic renal failure","volume":"52","author":"B Schneeweiss","year":"1990","journal-title":"Am J Clin Nutr"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S1051-2276(01)70038-6","article-title":"Resting metabolic rate in chronic renal failure","volume":"11","author":"U Kuhlmann","year":"2001","journal-title":"J Ren Nutr"},{"key":"ref8","first-page":"253","article-title":"Chronic kidney disease and cancer: a troubling connection","volume":"23","author":"B Stengel","year":"2010","journal-title":"J Nephrol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1172\/JCI114857","article-title":"Skeletal muscle metabolism is a major determinant of resting energy expenditure","volume":"86","author":"F Zurlo","year":"1990","journal-title":"J Clin Invest"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1053\/j.jrn.2010.10.018","article-title":"Energy intake and energy expenditure profiles in peritoneal dialysis patients","volume":"21","author":"AY-M Wang","year":"2011","journal-title":"J Ren Nutr"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"360","DOI":"10.5414\/CNP59360","article-title":"Resting energy expenditure in chronic kidney disease: relationship with glomerular filtration rate","volume":"59","author":"A Panesar","year":"2003","journal-title":"Clin Nephrol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/ndt\/gfq452","article-title":"Are prediction equations reliable for estimating resting energy expenditure in chronic kidney disease patients?","volume":"26","author":"MA Kamimura","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nature10777","article-title":"A PGC1-\u03b1-dependent myokine that drives brown-fat-like development of white fat and thermogenesis","volume":"481","author":"P Bostr\u00f6m","year":"2012","journal-title":"Nature"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.cmet.2012.02.010","article-title":"Irisin, turning up the heat","volume":"15","author":"F Villarroya","year":"2012","journal-title":"Cell Metab"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1126\/science.1221688","article-title":"Medicine. Irisin, light my fire","volume":"336","author":"DP Kelly","year":"2012","journal-title":"Science"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Huh JY, Panagiotou G, Mougios V, Brinkoetter M, Vamvini MT, <etal>et al<\/etal>.. (2012) FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metab Clin Exp. doi:10.1016\/j.metabol.2012.09.002.","DOI":"10.1016\/j.metabol.2012.09.002"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10715769900300551","article-title":"Hydroxyl radical generation and lipid peroxidation in C2C12 myotube treated with iodoacetate and cyanide","volume":"31","author":"N Matsuki","year":"1999","journal-title":"Free Radic Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1681\/ASN.2010111144","article-title":"Uremia alters HDL composition and function","volume":"22","author":"M Holzer","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.jacc.2007.06.018","article-title":"The relationship between renal function and cardiac structure, function, and prognosis after myocardial infarction: the VALIANT Echo Study","volume":"50","author":"A Verma","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1161\/CIRCRESAHA.112.278457","article-title":"Cardiorenal syndrome: the emerging role of protein-bound uremic toxins","volume":"111","author":"S Lekawanvijit","year":"2012","journal-title":"Circ Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.2215\/CJN.03980609","article-title":"Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients","volume":"4","author":"FC Barreto","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e41281","DOI":"10.1371\/journal.pone.0041281","article-title":"Chronic kidney disease-induced cardiac fibrosis is ameliorated by reducing circulating levels of a non-dialysable uremic toxin, indoxyl sulfate","volume":"7","author":"S Lekawanvijit","year":"2012","journal-title":"PLoS ONE"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/01.ASN.0000046029.53933.09","article-title":"Insulin resistance and risk of chronic kidney disease in nondiabetic US adults","volume":"14","author":"J Chen","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1053\/j.ajkd.2004.09.034","article-title":"Insulin resistance in patients with chronic kidney disease","volume":"45","author":"S Kobayashi","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1161\/hq0701.092147","article-title":"Does exercise increase HDL cholesterol in those who need it the most?","volume":"21","author":"PD Thompson","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/0026-0495(83)90141-5","article-title":"Increases in HDL-cholesterol and the HDL\/LDL cholesterol ratio during prolonged endurance exercise","volume":"32","author":"JL Durstine","year":"1983","journal-title":"Metab Clin Exp"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1161\/hq0701.092137","article-title":"Effects of endurance exercise training on plasma HDL cholesterol levels depend on levels of triglycerides: evidence from men of the Health, Risk Factors, Exercise Training and Genetics (HERITAGE) Family Study","volume":"21","author":"C Couillard","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1749-6632.2012.06480.x","article-title":"LDL-cholesterol versus HDL-cholesterol in the atherosclerotic plaque: inflammatory resolution versus thrombotic chaos","volume":"1254","author":"L Badimon","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s11883-011-0189-9","article-title":"Progress in HDL-based therapies for atherosclerosis","volume":"13","author":"K-Y Chyu","year":"2011","journal-title":"Curr Atheroscler Rep"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1161\/01.CIR.102.16.1893","article-title":"Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors: the Prospective Pravastatin Pooling Project","volume":"102","author":"FM Sacks","year":"2000","journal-title":"Circulation"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/nrcardio.2010.200","article-title":"Novel HDL-directed pharmacotherapeutic strategies","volume":"8","author":"EM Degoma","year":"2011","journal-title":"Nat Rev Cardiol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0064025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T12:49:39Z","timestamp":1589028579000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0064025"}},"subtitle":[],"editor":[{"given":"Anindita","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,5,7]]},"references-count":31,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,5,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0064025","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,7]]}}}